Skip to main content

Lenders have until Friday to work through the A&E request for Carlyle-owned NEP as the broadcast and live production services company tries to push the 2025 maturities on its $1.42bn dollar and $519mn-equivalent euro term loans out to the summer of 2026, an extension of less than a year for the Caa1/B-/B- rated business (Moody’s/S&P/Fitch).

The transaction is being described by lenders as “self-help” and a “band-aid” deal, to give the sponsor time to find a long-term solution for what is fundamentally a good business. It was presounded among the larger lenders, so a sizeable portion of the syndicate is already comfortable with the terms, sources said.

Unlike vanilla A&E requests, NEP is proposing to add a PIK element onto the existing cash-pay margin, plus a PIK upfront fee, and a 2% cash exit fee (details below).

One of the features of the transaction is that any lenders who stay in an unextended stub piece will become second in line to receive repayments from asset disposals, behind those that agree to extend. On other deals, such as Amneal and Keter, differing treatment of extending and non-extending lenders has met resistance from lenders in the US and Europe, although those cases involved stripping collateral from unextended debt.

CLO managers will also need to be comfortable taking part of their compensation in PIK format – although the mix of PIK and cash-pay should help with that, say sources – and with the ratings aspect.

During the year, A&E deals have often resulted in a rating upgrade as the borrower in question shows that it is managing the risk inherent in having short debt maturities. But in this instance, NEP’s ratings, including the Caa1 from Moody’s, are not expected to improve immediately on the back of the deal.

Moody’s cites concerns about weak free cash flow and a high interest burden, noting debt of $2.5bn including the second-lien. Further, Moody’s has said the deal is likely to be classed as a distressed exchange, potentially adding another complexity for CLO managers.

As part of the offer to investors, Carlyle has materially amended the documentation in lenders’ favour. The extended loans don’t feature aggressive language around priming and numerous other points that have become common in loan terms, a buysider says.

Covenant Review had previously given the documentation a composite score of 4-, but that has now moved to 3+ in a reflection of the changes. The scores published on the extended initial dollar loan are as follows: Composite Score 3+, Collateral Protection 2-, Default Protection 3+, and Lenders’ Repricing Optionality 3+.

Prospects beyond

Looking at the further prospects for NEP, the key development will be the sale of its live events division, say buysiders. In September, the borrower was reported to be exploring a sale of this asset that could raise up to $2bn. If the sale goes ahead, it could open the way for a refinancing of the remaining debt on regular terms, or the sponsor might choose to put the whole company on the block, buysiders say.

Support for the extension is also helped by NEP’s leading position in the industry, and the business should have a strong year ahead in 2024 with the Olympics and other events coming up.

The sponsor has not injected fresh equity as part of the A&E, according to sources, but has previously done so to help with liquidity issues, including $95mn earlier this year.

A spokesperson for Carlyle declined to comment on the transaction.

Away from NEP, there are some other cross-border deals with 2025 maturities and low ratings, that will need to be addressed soon. One of these, also owned by Carlyle, is Veritas, which was recently cut to CCC+ by S&P, while Clearlake-backed Alkegen (formerly Unifrax) was downgraded by S&P to CCC+ in the summer. Both have dollar and euro first-lien term loans due 2025.

Price talk

Price talk on NEP currently runs as follows:

– The $1.092bn August 19, 2026 TLB is guided S+325bps with a 0% floor, plus 150bps accrued PIK interest, a 150bps PIK upfront fee, and a 200bps cash exit fee.

– The $123mn incremental June 1, 2026 TLB is guided S+825bps with a 1% floor, plus 150bps accrued PIK interest, a 200bps PIK upfront fee, and a 200bps cash exit fee.

– The $209mn August 19, 2026 incremental TLB is guided S+400bps with a 0.5% floor, plus 150bps accrued PIK interest, a 150bps PIK upfront fee, and a 200bps cash exit fee.

– The $519mn-equivalent August 19, 2026 euro TLB is guided E+350bps with a 0% floor, plus 150bps accrued PIK interest, a 150bps PIK upfront fee, and a 200bps cash exit fee.

Barclays (lead left), JPMorgan, HSBC, Macquarie, MUFG, Mizuho and PNC are bookrunners. Barclays is also agent.

Replies are due on December 15 at 12:00 UKT and 12:00 NYT.

The issuer’s originally $1.13bn/€397mn TLBs due October 2025 were syndicated in 2018 alongside an originally $240mn second-lien term loan due October 2026, as part of a cross-border financing supporting Carlyle Group’s acquisition of Crestview Holdings’ remaining stake in the company. Incremental facilities followed, mainly to repay RCF drawings.

Ruth McGavin
+44 (0)20 3530 1457

Richard Budden
+44 (0)20 7280 9691


This Report is for informational purposes only. Neither the information contained in this Report, nor any opinion expressed therein is intended as an offer or solicitation with respect to the purchase or sale of any security or as personalized investment advice. CreditSights and its affiliates do not recommend the purchase or sale of financial products or securities, and do not give investment advice or provide any legal, auditing, accounting, appraisal, valuation or actuarial services. Neither CreditSights nor the persons involved in preparing this Report or their respective households has a financial interest in the securities discussed herein. Recommendations made in a report may not be suitable for all investors and do not take into account any particular user’s investment risk tolerance, return objectives, asset allocation, investment horizon, or any other factors or constraints. Information included in any article that includes analysis of documents, agreements, controversies, or proceedings is for informational purposes only and does not constitute legal advice. No attorney client relationship is created between any reader and CreditSights as a result of the publication of any research report, or any response provided by CreditSights (including, but not limited to, the ask an analyst feature or any other analyst interaction) or as the result of the payment to CreditSights of subscription fees. The material included in an article may not reflect the most current legal developments. We disclaim all liability in respect to actions taken or not taken based on any or all the contents of any research report or communication to the fullest extent permitted by law. Reproduction of this report, even for internal distribution, is strictly prohibited. Receipt and review of this research report constitutes your agreement not to redistribute, retransmit, or disclose to others the contents, opinions, conclusion or information contained in this report (including any investment recommendations or estimates) without first obtaining express permission from CreditSights. The information in this Report has been obtained from sources believed to be reliable; however, neither its accuracy, nor completeness, nor the opinions based thereon are guaranteed. The products are being provided to the user on an “as is” basis, exclusive of any express or implied warranty or representation of any kind, including as to the accuracy, timeliness, completeness, or merchantability or fitness for any particular purpose of the report or of any such information or data, or that the report will meet any user’s requirements. CreditSights may issue or may have issued other reports that are inconsistent with or may reach different conclusions than those represented in this Report, and all opinions are reflective of judgments made on the original date of publication. CreditSights is under no obligation to ensure that other reports are brought to the attention of any recipient of the Products. Certain data appearing herein is owned by, and used under license from, certain third parties. Please see Legal Notices for important information and limitations regarding such data. For terms of use, see Terms & Conditions.
If you have any questions regarding the contents of this report contact CreditSights at
© 2023. CreditSights, Inc. All rights reserved.